Learn how to understand Big O notation and algorithm complexity in this practical guide. Master algorithm analysis, optimize code performance, and scale your applications with confidence.
Overview of the NodaLogic low-code platform for creating mobile and web solutions with AI-generation. Learn about node architecture, use cases, and development optimization.
Analysis of OWASP Agentic Top 10 2026 and Lethal Trifecta for protecting AI agents. Countermeasures against goal hijack, RCE, memory poisoning. Practical roadmap for middle/senior dev.
Learn how Nuxeo implements lifecycle and schemas for mortgage applications without microservices. Declarative model, transition automation. For developers: XSD and configuration examples. Test it yourself.
Morgan Stanley filed applications for Ethereum and Solana ETFs with a 0.14% fee and staking. Learn how this will change the crypto-ETF market and affect investors.
Gamaleya and FMBA cancer vaccines will become free under compulsory health insurance. CAR-T for 7 million rubles and personalized course for 5.8 million. Find out who is eligible for Oncopept and how many applications have already been approved.
The European Commission has started a revision of MiCA due to zero applications for ARTs. Reasons for failure and forecasts for stablecoins. Find out what will change by 2027.
ViiV has submitted applications to the FDA and EMA for dispersible Dovato tablets for children. We analyze the strategy, patents, and implications. Find out who will win.
Learn how does blockchain technology work in this complete beginner's guide. Discover key concepts, real-world applications, and why it matters for your future.
EMA validated the application for the use of Dovato in children from 3 months with HIV. Learn how this will change pediatric therapy and strengthen ViiV's position. Read the detailed analysis.
Intellia has filed the world's first application for an in vivo CRISPR therapy, lonvo-z, for hereditary angioedema (HAE). 87% reduction in attacks, 62% attack-free. Risk, market, and forecast analysis. Read.
Scientists have completed the pivotal study of the Ottava robot (FORTE) and are preparing an FDA application. Learn about clinical data, zero conversions, and market prospects for robotic surgery.
From the web
My Apps
https://myapplications.microsoft.com/
You need to enable JavaScript to run this app. My Apps.